Itamar Raz,Roni Weinberg Sibony,Saar Dor et al.
Itamar Raz et al.
Aims: To examine the efficacy and safety of Curalin, as a supplement to anti-diabetic drugs (ADD). Methods: 135 patients were enrolled ...
Randomized Controlled Trial
Diabetes research and clinical practice. 2024 Dec:218:111912. DOI:10.1016/j.diabres.2024.111912 2024
Reproductive factors predict risks of cardiovascular disease and premature death in postmenopausal women with type 2 diabetes: The Fukuoka Diabetes Registry [0.03%]
生育因素预测福冈糖尿病登记册中绝经后2型糖尿病女性心血管疾病和过早死亡的风险
Ayaka Oshiro,Toshiaki Ohkuma,Masanori Iwase et al.
Ayaka Oshiro et al.
Aims: Reproductive factors (reproductive period, age at menarche, and age at menopause) are associated with a risk of cardiovascular disease (CVD) and death in individuals without focusing on comorbid diabetes. However, i...
Real-world efficacy and safety of open-source automated insulin delivery for people with type 1 diabetes mellitus: Experience from mainland China [0.03%]
中国大陆1型糖尿病患者开源自动化胰岛素输注系统的现实有效性和安全性：经验分享
Yongwen Zhou,Mengyun Lei,Daizhi Yang et al.
Yongwen Zhou et al.
Background: Open-source automated insulin delivery systems are increasingly adopted yet predominantly discussed outside of Asia. This study aimed to describe efficacy and safety of android artificial pancreas (AAPS) in pe...
Cardiovascular disease modifies the relationship between systolic blood pressure and outcomes in people with diabetes [0.03%]
心血管疾病改变糖尿病患者收缩压与预后的关系
Anping Cai,Jiabin Wang,Xiaoxuan Feng et al.
Anping Cai et al.
Objective: We aimed to evaluate the influences of cardiovascular disease (CVD) on the relationship between baseline systolic blood pressure (SBP) and outcomes in community populations with diabetes. ...
Observational Study
Diabetes research and clinical practice. 2024 Dec:218:111909. DOI:10.1016/j.diabres.2024.111909 2024
Salivary glycated albumin could be as reliable a marker of glycemic control as blood glycated albumin in people with diabetes [0.03%]
糖尿病患者唾液糖化白蛋白可能与血液糖化白蛋白一样可靠地反映血糖控制水平
Masakazu Aihara,Kouji Yano,Tomoko Irie et al.
Masakazu Aihara et al.
Aims: Measurements of diabetes-related biomarkers are necessary to assess glycemic control. The commonly used finger-prick blood glucose and HbA1c measurements are invasive, as is blood glycated albumin (GA) measurement. ...
Unraveling the impaired incretin effect in obesity and type 2 diabetes: Key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload [0.03%]
肥胖和2型糖尿病中胰岛素原作用受损的机制：高血糖诱导的糖酵解异常激活及过度激活的关键作用
Naila Rabbani,Paul J Thornalley
Naila Rabbani
Glucagon-like peptide-1 (GLP-1) agonists and GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) co-agonists are major treatment options for subjects with obesity and patients with type 2 diabetes mellitus (T2DM). They counter with...
Pancreatic fat infiltration is associated with risk of vertebral fracture in older patients with type 2 diabetes: A longitudinal multicenter study [0.03%]
胰脂肪浸润与2型糖尿病老年患者的椎体骨折风险相关：一项前瞻性多中心研究
Jiangchuan Wang,Zicheng Wei,Yu Wang et al.
Jiangchuan Wang et al.
Aims: Patients with type 2diabetesmellitus (T2DM) have high fracture risk. This study explored the associations between pancreatic computed tomography (CT) attenuation, a marker of pancreatic fat, and risk of vertebral fr...
Virtual diagnosis of diabetic nephropathy using metabolomics in place of kidney biopsy: The DIAMOND study [0.03%]
基于代谢组学的糖尿病肾病虚拟诊断与肾脏穿刺活检的DIAMOND研究
Da Woon Kim,Hyo Jin Kim,Eun Young Seong et al.
Da Woon Kim et al.
Aims: To explore the clinical factors and urinary metabolites that predict biopsy-confirmed diabetic nephropathy (DN) in patients with type 2 diabetes mellitus (T2DM). ...
Once-weekly insulin icodec as novel treatment for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials [0.03%]
一周一次的胰岛素icodec作为2型糖尿病新疗法：随机临床试验的系统评价和荟萃分析
Nanny Natalia Mulyani Soetedjo,Hikmat Permana,Timotius Ivan Hariyanto et al.
Nanny Natalia Mulyani Soetedjo et al.
Aims: The primary objective of this investigation is to examine the efficacy and safety of insulin icodec when compared to regular basal insulin for the management of type 2 diabetes mellitus (T2DM). ...